BalchemBCPC
Market Cap: 806M
About: Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) The Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) The Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia.
Employees: 1,301
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
40,592,000% more capital invested
Capital invested by funds: $0 [Q4 2023] → $406K (+$406K) [Q1 2024]
100% more funds holding
Funds holding: 0 [Q4 2023] → 1 (+1) [Q1 2024]
100% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 0
0.17% more ownership
Funds ownership: 0% [Q4 2023] → 0.17% (+0.17%) [Q1 2024]
Research analyst outlook
2 Wall Street Analysts provided 1 year price forecasts over the past 6 months
2 analyst ratings
HC Wainwright & Co. Raghuram Selvaraju | 584%upside $170 | Buy Maintained | 6 May 2024 |
HC Wainwright & Co. Raghuram Selvaraju | 572%upside $167 | Buy Maintained | 20 Feb 2024 |
Financial journalist opinion
Based on 9 articles about BCPC published over the past 30 days